WBA Oct 2024 17.500 put
| Previous close | 6.45 |
| Open | 6.03 |
| Bid | 5.85 |
| Ask | 6.95 |
| Strike | 17.50 |
| Expiry date | 2024-10-18 |
| Day's range | 6.03 - 6.03 |
| Contract range | N/A |
| Volume | |
| Open interest | 4.06k |
BloombergJPMorgan Sounds Out Investors on Potential Walgreens Junk Bond
(Bloomberg) -- JPMorgan Chase & Co. is sounding out investors on a potential high-yield bond sale by Walgreens Boots Alliance Inc. to address the recently downgraded drug-store chain’s near-term debt maturities, according to people familiar with the matter. Most Read from BloombergTrump Risks Losing Voters He Needs With Loaded Attacks on HarrisHarris Just Showed Why Trump Is So Afraid of HerMarkets Tear Up Popular Trades That Reached ‘Stupid Levels’Stocks Caught in Tug of War Between Tech and Re
- Thomson Reuters StreetEvents
Q2 2024 Agree Realty Corp Earnings Call
Q2 2024 Agree Realty Corp Earnings Call
Business WireWalgreens Receives BARDA Project NextGen Award to Conduct Novel COVID-19 Decentralized Clinical Study
DEERFIELD, Ill., July 23, 2024--Walgreens today announced it received a project award valued up to $25 million through the Rapid Response Partnership Vehicle (RRPV) to conduct a Phase IV observational clinical study focused on assessing Correlates of Protection (CoP), known as responses to a vaccine that predict how well a vaccinated person will be protected from future infections, using COVID-19 vaccine data. The RRPV is a Consortium funded by the Biomedical Advanced Research and Development Au
